Using UNC's expertise to fight emerging diseases

Posted Jul 13, 2018
Gilead Sciences, Inc., and Carolina are teaming up to save lives. The biopharmaceutical company sought the University's resources and talents in the development of treatments to control disease outbreaks. Imagine: One drug with the potential to treat MERS, SARS, Ebola, and the common cold. At Carolina, researchers are imagining — and enabling — just that. (UNC.edu)

Related: Campus Connections

Michael Jordan’s historic $10 million gift honors mother, expands UNC School of Social Work’s impact
In honor of his mother, Deloris P. Jordan, Michael Jordan has made a $10 million commitment to the UNC School of Social Work. The largest...
Mon Oct 5, 2026

Audio: 100 Years of Kenan Stadium - Commencement VIPs
You never know who you’ll see at Kenan Stadium. For Chapelboro’s own Kenny Dike, his commencement in the spring of 2001 featured a few special...
Tue Sep 29, 2026

A guide to the most iconic UNC campus characters
The beloved campus crossing guards by South Road have left the most positive effect on my time at UNC out of any of the campus...
Sun Sep 27, 2026

Video: Carolina Insider - Ken Cleary On Montross Day Of Service
UNC Assistant Athletic Director for New Media Ken Cleary discusses his role in GoHeels Productions (1:14), his personal journey with cancer and recovery (12:47), and...
Fri Sep 25, 2026